PARLIAMENTARY WRITTEN QUESTION
(29 August 2025)
Question Asked
Asked by:
Dr Allison Gardner (Labour)
Answer
The Department is aware of supply issues affecting potassium chloride 375mg/5ml syrup (Kay-Cee-L® syrup). We issued comprehensive communications to healthcare professionals which includes guidance on how to manage affected patients during the shortage.
Alternative formulations of potassium effervescent tablets remain available, and the Department has reached out to specialist importers who have sourced unlicensed potassium chloride oral solution for patients.
The Department is aware that this product has been divested to another manufacturer. We are working closely with the new manufacturer and the Medicines and Healthcare products Regulatory Agency to expedite regulatory procedures where possible to ensure that supplies of licensed potassium chloride syrup are made available as soon as possible.
Answered by:
()
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.